1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Europe Exosome Diagnostic and Therapeutic Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Europe Exosome Diagnostic and Therapeutic Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Europe Exosome Diagnostic and Therapeutic Market Regional Analysis
6.2 Europe Exosome Diagnostic and Therapeutic Market Revenue 2017-2027 (US$ Thousand)
6.3 Europe Exosome Diagnostic and Therapeutic Market Forecast Analysis
7. Europe Exosome Diagnostic and Therapeutic Market Analysis – by Application
7.1 Diagnostic
- 7.1.1 Overview
- 7.1.2 Diagnostic: Europe Exosome Diagnostic and Therapeutic Market – Revenue and Forecast, 2017-2027 (US$ Thousand)
7.2 Therapeutic
- 7.2.1 Overview
- 7.2.2 Therapeutic: Europe Exosome Diagnostic and Therapeutic Market – Revenue and Forecast, 2017-2027 (US$ Thousand)
8. Europe Exosome Diagnostic and Therapeutic Market Analysis – by Product
8.1 Instruments
- 8.1.1 Overview
- 8.1.2 Instruments: Europe Exosome Diagnostic and Therapeutic Market – Revenue and Forecast, 2017-2027 (US$ Thousand)
8.2 Reagents
- 8.2.1 Overview
- 8.2.2 Reagents: Europe Exosome Diagnostic and Therapeutic Market – Revenue and Forecast, 2017-2027 (US$ Thousand)
8.3 Software
- 8.3.1 Overview
- 8.3.2 Software: Europe Exosome Diagnostic and Therapeutic Market – Revenue and Forecast, 2017-2027 (US$ Thousand)
9. Europe Exosome Diagnostic and Therapeutic Market Analysis – by End User
9.1 Cancer Institute
- 9.1.1 Overview
- 9.1.2 Cancer Institute: Europe Exosome Diagnostic and Therapeutic Market – Revenue and Forecast, 2017-2027 (US$ Thousand)
9.2 Hospitals
- 9.2.1 Overview
- 9.2.2 Hospitals: Europe Exosome Diagnostic and Therapeutic Market – Revenue and Forecast, 2017-2027 (US$ Thousand)
9.3 Diagnostic Centers
- 9.3.1 Overview
- 9.3.2 Diagnostic Centers: Europe Exosome Diagnostic and Therapeutic Market – Revenue and Forecast, 2017-2027 (US$ Thousand)
9.4 Other End Users
- 9.4.1 Overview
- 9.4.2 Other End Users: Europe Exosome Diagnostic and Therapeutic Market – Revenue and Forecast, 2017-2027 (US$ Thousand)
10. Europe Exosome Diagnostic and Therapeutic Market – Europe Analysis
10.1 Overview
10.2 Europe
- 10.2.1 Europe Exosome Diagnostic and Therapeutic Market Breakdown, by Key
Country, 2020 and 2027 (%)
- 10.2.1.1 Europe Exosome Diagnostic and Therapeutic Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 UK:
Europe Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)
- 10.2.1.1.1 UK: Europe Exosome Diagnostic and Therapeutic Market Breakdown, by Application
- 10.2.1.1.2 UK: Europe Exosome Diagnostic and Therapeutic Market Breakdown, by Product
- 10.2.1.1.3 UK: Europe Exosome Diagnostic and Therapeutic Market Breakdown, by End User
- 10.2.1.2 Germany:
Europe Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)
- 10.2.1.2.1 Germany: Europe Exosome Diagnostic and Therapeutic Market Breakdown, by Application
- 10.2.1.2.2 Germany: Europe Exosome Diagnostic and Therapeutic Market Breakdown, by Product
- 10.2.1.2.3 Germany: Europe Exosome Diagnostic and Therapeutic Market Breakdown, by End User
- 10.2.1.3 France:
Europe Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)
- 10.2.1.3.1 France: Europe Exosome Diagnostic and Therapeutic Market Breakdown, by Application
- 10.2.1.3.2 France: Europe Exosome Diagnostic and Therapeutic Market Breakdown, by Product
- 10.2.1.3.3 France: Europe Exosome Diagnostic and Therapeutic Market Breakdown, by End User
- 10.2.1.4 Russia:
Europe Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)
- 10.2.1.4.1 Russia: Europe Exosome Diagnostic and Therapeutic Market Breakdown, by Application
- 10.2.1.4.2 Russia: Europe Exosome Diagnostic and Therapeutic Market Breakdown, by Product
- 10.2.1.4.3 Russia: Europe Exosome Diagnostic and Therapeutic Market Breakdown, by End User
- 10.2.1.5 Italy:
Europe Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)
- 10.2.1.5.1 Italy: Europe Exosome Diagnostic and Therapeutic Market Breakdown, by Application
- 10.2.1.5.2 Italy: Europe Exosome Diagnostic and Therapeutic Market Breakdown, by Product
- 10.2.1.5.3 Italy: Europe Exosome Diagnostic and Therapeutic Market Breakdown, by End User
- 10.2.1.6 Rest of Europe:
Europe Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)
- 10.2.1.6.1 Rest of Europe: Europe Exosome Diagnostic and Therapeutic Market Breakdown, by Application
- 10.2.1.6.2 Rest of Europe: Europe Exosome Diagnostic and Therapeutic Market Breakdown, by Product
- 10.2.1.6.3 Rest of Europe: Europe Exosome Diagnostic and Therapeutic Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Cell Guidance Systems
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Evomic Science LLC
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Exosome Diagnostics
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 ITH, Immune Therapy Holdings AB
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Miltenyi Biotec
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Norgen Biotek Corp
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Reneuron Group Plc
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Get Free Sample For Europe Exosome Diagnostic and Therapeutic Market
